Christian Perea

[ESTRO @ESTRO_RT]

Spatially Fractionated Radiotherapy (SFRT) is on the rise! 🚀
Missed the #SFRT research wave at #ESTRO26? The ESTRO SFRT Focus Group compiled every relevant presentation, symposium, & digital poster into one comprehensive report.
👉 https://t.co/rRqR7fcnR6
#RadOnc #radiotherapy

[ImpactoEterno @ImpactoEterno]

Cancela tu suscripción a Netflix si no has visto estas 11 películas imprescindibles. 🎬

Un hilo 🧵

Guárdatelo para más tarde 🔖

[Speed of Light - The ASTRO Foundation @SpeedofLightFdn]

ICYMI the eContouring for Breast Cancer webinar is now available on demand! Watch at https://t.co/Wy07xwhAjp. Dr. Mylin Torres discusses guiding principles for RT, field design & more. Presented by @ASTRO_org Academy & free to all w/ support from the ROI Juan A. del Regato Fund

[Castalia Fernández, MD. @FuenteApolo]

Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline #bcsm #radonc #APBI 2023. @OncoAlert
https://t.co/qSItTuWRbq

[Shannon Westin, MD, MPH, FASCO @ShannonWestin]

🙌INTERLACE trial - induction chemotherapy + chemoXRT vs chemoXRT alone in locally advanced #CervicalCancer
✅🤩Compliance was good
Induction yielded increased
Progression free survival: HR 0.65 (p-0.013)
Overall survival: HR 0.61 (p=0.04)
#gyncsm #radonc #ESMO2023

[ESMO - Eur. Oncology @myESMO]

#ESMO23:Presidential Symposium presentation of GCIG INTERLACE trial shows induction #chemotherapy before chemoradiotherapy significantly improves PFS and OS in locally advanced #CervicalCancer (IB1/2 to IVA) @AnaOaknin #ESMODailyReporter 👉https://t.co/8s5oV18h49

[ESTRO @ESTRO_RT]

📌 Just published in the Green Journal @RadiotherapyOn1: ESTRO clinical practice guideline: Stereotactic Body Radiotherapy for Spine metastases.
🔗 Open access: https://t.co/QFSVA3kagf
@Mat_Guc @alongi_filippo

[Christian Perea @drckpo]

https://t.co/yhdwKU7DaR

[Christian Perea @drckpo]

ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023 - Radiotherapy and Oncology https://t.co/r5OQEFlisa

[Jame Abraham, MD, FACP @jamecancerdoc]

Artificial Intelligence and Machine Learning in Clinical Medicine, 2023 | @NEJM @OncoAlert https://t.co/4boP9XbGPD

[Neeraj Agarwal, MD, FASCO @neerajaiims]

#ASCO23 @asco PEACE-1 trial by Dr. Bossi👉Significant delay in disease progression and delay of serious GU obstructive events by radiation therapy in mCSPC (no OS benefit): results confirm the role of radiation in low volume denovo mCSPC @OncoAlert @urotoday @PCFnews

[Shankar Siva @_ShankarSiva]

Late breaking #ESTRO2023 - HypoG-01. N=1,222 patients, ➡️ non-inferiority of hypofractionated #breastcancer radiotherapy in patients needing nodal irradiation. ➡️Primary endpoint lymphoedema 24% vs 23%; ➡️secondary shoulder movement 23% vs 26%
➡️ no drop in safety, LRF #radonc

[Vivian Tan MD @drviviantan]

Published “Top 10 Lessons Learned from Trials in Oligometastatic Cancers” in CRT reviewing #SABR outcomes, toxicity, costs, combination with systemic therapies and barriers to accrual for trials
@drdavidpalma #radonc #onctwitter #medtwitter
https://t.co/RK8pBBRPZ4

[ESTRO @ESTRO_RT]

#ESTROnewsletter Intensity-modulated radiation therapy reduces patient-reported chronic toxicity compared with conventional pelvic radiation therapy: Updated results of a phase III trial https://t.co/lnitgU5hOj

[SGRT Community @SGRTCommunity]

The Hospital de la Santa Creu i Sant Pau team treated their first-ever hepatic SBRT in EEBH (End Expiration Breath Hold) using SGRT.

This is the first treatment of its kind with AlignRT in Spain & the team plans to use the SBRT- EEBH technique with AlignRT for other locations.

[Christian Perea @drckpo]

@Dr_Blazquez @Bolivar_Divisa Encontré 12 !!!

[Christian Perea @drckpo]

Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial - European Urology https://t.co/VB7ptW4i3N

[Angel Montero Luis @Monthy_A]

Lattice or Oxygen-Guided Radiotherapy: What If They Converge? Possible Future Directions in the Era of Immunotherapy #radonc https://t.co/q2xznB2nmg ##mdpicancers a través de @Cancers_MDPI

[Shankar Siva @_ShankarSiva]

🇩🇪 🇦🇹German/Austrian RCT of SABR in oligometastatic #breastcancer (OLIGOMA) - 💕 the ambitious protocol on the cards, seeking n = 564 participants across 50 centres. Protocol now available; https://t.co/sp9LQcf3jU #bcsm

[Christian Perea @drckpo]

Dos ingenieros peruanos ganan beca a Sillicon Valley http://t.co/d2CDm3JYt2